Skip to main content

Table 3 Toxicities by HSCT and infection

From: Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

Toxicity

HLA-matched HSCT

Haploidentical HSCT

P

Hepatic

 Transaminase elevation

8(22.9 %)

14(29.8 %)

0.484

 Bilirubin elevation

3(8.6 %)

9(19.1 %)

0.180

Gastrointestinal tract

 Diarrhea

25(71.4 %)

33(70.2)

0.905

 Nausea and vomiting

17(48.6 %)

32(68.1 %)

0.075

 Mucositis

13(37.1 %)

21(44.7 %)

0.493

 Alimentary tract hemorrhage

2(5.7 %)

6(12.8)

0.287

Urinary tract/kidney

 Creatinine elevation

0

1(2.1)

0.385

 Hemorrhagic cystitis

1(2.9 %)

1

0.832

Infection

 Bacterial infection

23(65.7 %)

32(68.1 %)

0.821

 Fungal infection

4(11.4 %)

8(17.0 %)

0.479

 CMV infection

5(14.3 %)

18(38.3 %)

0.017

Cardiovascular

 Heart dysfunction

1

0

0.244

  1. CMV cytomegalovirus